Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Non-Current Debt (2017 - 2023)

Historic Non-Current Debt for Marimed (MRMD) over the last 7 years, with Q3 2023 value amounting to $18.9 million.

  • Marimed's Non-Current Debt changed N/A to $18.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was $18.9 million, marking a year-over-year change of. This contributed to the annual value of $17.3 million for FY2021, which is 6159.54% up from last year.
  • Per Marimed's latest filing, its Non-Current Debt stood at $18.9 million for Q3 2023.
  • Marimed's Non-Current Debt's 5-year high stood at $20.8 million during Q1 2023, with a 5-year trough of $46000.0 in Q1 2022.
  • Moreover, its 5-year median value for Non-Current Debt was $10.7 million (2020), whereas its average is $9.6 million.
  • In the last 5 years, Marimed's Non-Current Debt crashed by 9857.85% in 2022 and then surged by 4512391.3% in 2023.
  • Quarter analysis of 5 years shows Marimed's Non-Current Debt stood at $980000.0 in 2019, then surged by 990.02% to $10.7 million in 2020, then surged by 61.6% to $17.3 million in 2021, then tumbled by 99.73% to $46000.0 in 2022, then skyrocketed by 40976.09% to $18.9 million in 2023.
  • Its Non-Current Debt stands at $18.9 million for Q3 2023, versus $20.5 million for Q2 2023 and $20.8 million for Q1 2023.